These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32596635)
1. Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers. Jia G; Lu Y; Wen W; Long J; Liu Y; Tao R; Li B; Denny JC; Shu XO; Zheng W JNCI Cancer Spectr; 2020 Jun; 4(3):pkaa021. PubMed ID: 32596635 [TBL] [Abstract][Full Text] [Related]
2. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study. Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J Elife; 2023 Mar; 12():. PubMed ID: 36971353 [TBL] [Abstract][Full Text] [Related]
3. Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants. Choi J; Jia G; Wen W; Long J; Zheng W Int J Cancer; 2020 Dec; 147(12):3416-3423. PubMed ID: 32588423 [TBL] [Abstract][Full Text] [Related]
4. Utility of polygenic risk scores in UK cancer screening: a modelling analysis. Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Roberts MR; Asgari MM; Toland AE Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599 [TBL] [Abstract][Full Text] [Related]
6. Associations of genetic susceptibility to 16 cancers with risk of breast cancer overall and by intrinsic subtypes. Choi J; Jia G; Wen W; Tao R; Long J; Shu XO; Zheng W HGG Adv; 2022 Jan; 3(1):100077. PubMed ID: 35047862 [TBL] [Abstract][Full Text] [Related]
7. Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice. Padrik P; Puustusmaa M; Tõnisson N; Kolk B; Saar R; Padrik A; Tasa T Breast Cancer (Auckl); 2023; 17():11782234231205700. PubMed ID: 37842230 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification. Olsen M; Fischer K; Bossuyt PM; Goetghebeur E BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164 [TBL] [Abstract][Full Text] [Related]
9. Using clinical and genetic risk factors for risk prediction of 8 cancers in the UK Biobank. Hu J; Ye Y; Zhou G; Zhao H JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38366150 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606 [TBL] [Abstract][Full Text] [Related]
11. Association between the polygenic liabilities for prostate cancer and breast cancer with biochemical recurrence after radical prostatectomy for localized prostate cancer. Wang SH; Huang SP; Pan YJ; Hsiao PC; Li CY; Chen LC; Yu CC; Huang CY; Lin VC; Lu TL; Bao BY Am J Cancer Res; 2021; 11(5):2331-2342. PubMed ID: 34094689 [TBL] [Abstract][Full Text] [Related]
13. Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study. Ji C; Ge W; Zhu C; Shen F; Yu Y; Pang G; Li Q; Zhu M; Ma Z; Zhu X; Fu Y; Gong L; Wang T; Du L; Jin G; Zhu M Int J Cancer; 2025 Feb; 156(3):505-517. PubMed ID: 39291673 [TBL] [Abstract][Full Text] [Related]
14. Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set. Vince RA; Sun H; Singhal U; Schumacher FR; Trapl E; Rose J; Cullen J; Zaorsky N; Shoag J; Hartman H; Jia AY; Spratt DE; Fritsche LG; Morgan TM Eur Urol Oncol; 2024 May; ():. PubMed ID: 38734542 [TBL] [Abstract][Full Text] [Related]
15. Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention. Wang Y; Zhu M; Ma H; Shen H Med Rev (2021); 2021 Dec; 1(2):129-149. PubMed ID: 37724297 [TBL] [Abstract][Full Text] [Related]
16. Clinical features of prostate cancer by polygenic risk score. Spears C; Xu M; Shoben A; Dason S; Toland AE; Byrne L Fam Cancer; 2024 Nov; 23(4):499-505. PubMed ID: 38619781 [TBL] [Abstract][Full Text] [Related]
17. Polygenic Risk Scores Associated with Tumor Immune Infiltration in Common Cancers. Choi J; Kim JS; Sung HJ; Chen YW; Chen Z; Wen W; Shu XO; Guo X Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428664 [TBL] [Abstract][Full Text] [Related]
18. Assessing thyroid cancer risk using polygenic risk scores. Liyanarachchi S; Gudmundsson J; Ferkingstad E; He H; Jonasson JG; Tragante V; Asselbergs FW; Xu L; Kiemeney LA; Netea-Maier RT; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Brock P; Nabhan F; Thorleifsson G; Ringel MD; Stefansson K; de la Chapelle A Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5997-6002. PubMed ID: 32132206 [TBL] [Abstract][Full Text] [Related]
19. Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening. Jia G; Wen W; Massion PP; Shu XO; Zheng W Carcinogenesis; 2021 Jun; 42(6):874-879. PubMed ID: 33640962 [TBL] [Abstract][Full Text] [Related]
20. An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes. Liu W; Zhuang Z; Wang W; Huang T; Liu Z Front Genet; 2021; 12():632385. PubMed ID: 33643391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]